| OrPha Swiss GmbH - Ambrisentan OrPha 5 mg, Filmtabletten | | 67500 | | 01 | | Ambrisentan OrPha 5 mg | | Filmtabletten | | C02KX02 | | Ambrisentan | | 16.12.2022 | | |
| | Composition | | ambrisentanum 5 mg, cellulosum microcristallinum, lactosum monohydricum 47.5 mg, carmellosum natricum conexum corresp. natrium 0.16 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 129 0.022 mg, lecithinum ex soja, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Ambrisentanum | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Ambrisentanum | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 129 | 0.022 mg | color. | | E 171 | | color. | | Lactose Monohydrate | 47.5 mg | | | Lecithinum ex Soja | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 990.57 | 1093.70 | B | SL | Yes |
|
|
